| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |